The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Silverman Joshua | Executive Chairman, Director | Grant(A) | 100K | — | $0 |
| Apr 13, 2026 | Silverman Joshua | Executive Chairman, Director | Grant(A) | 162K | — | $0 |
| Apr 13, 2026 | White Billy Joe | Director | Grant(A) | 50K | — | $0 |
| Apr 13, 2026 | Voss Chelsea Sierra | Director | Grant(A) | 50K | — | $0 |
| Apr 13, 2026 | Glass Mitchell | Chief Medical Officer, Director | Grant(A) | 50K | — | $0 |
| Apr 13, 2026 | Friscia Stephen | Director | Grant(A) | 50K | — | $0 |
| Apr 13, 2026 | Bernstein Bruce | Director | Grant(A) | 50K | — | $0 |
| Mar 30, 2026 | Voss Chelsea Sierra | Director | Buy(P) | 2K | $3.15 | $6K |
| Jan 16, 2026 | Voss Chelsea Sierra | Director | Grant(A) | 25K | — | $0 |
| Jan 16, 2026 | Voss Chelsea Sierra | Director | Grant(A) | 213K | — | $0 |
| Jan 16, 2026 | Voss Chelsea Sierra | Director | Grant(A) | 213K | — | $0 |
| Nov 14, 2025 | Rauch Gary M | Insider | Grant(A) | 11K | — | $0 |
| Nov 14, 2025 | Bernstein Bruce | Director | Grant(A) | 25K | — | $0 |
| Nov 14, 2025 | Friscia Stephen | Director | Grant(A) | 23K | — | $0 |
| Nov 14, 2025 | Silverman Joshua | Executive Chairman, Director | Grant(A) | 91K | — | $0 |
| Nov 14, 2025 | White Billy Joe | Director | Grant(A) | 23K | — | $0 |
| Nov 14, 2025 | Glass Mitchell | Director, Chief Medical Off., Director | Grant(A) | 11K | — | $0 |
| Nov 14, 2025 | PharmaCyte Biotech, Inc. | 10% Owner | Buy(P) | 890K | — | — |
| Oct 3, 2025 | Friscia Stephen | Director | Grant(A) | 2K | — | $0 |
| Oct 3, 2025 | Glass Mitchell | Director, Chief Medical Off., Director | Grant(A) | 1K | — | $0 |
| Oct 3, 2025 | Rauch Gary M | Insider | Grant(A) | 1K | — | $0 |
| Oct 3, 2025 | Silverman Joshua | Executive Chairman, Director | Grant(A) | 9K | — | $0 |
| Oct 3, 2025 | White Billy Joe | Director | Grant(A) | 2K | — | $0 |
| Sep 4, 2025 | PharmaCyte Biotech, Inc. | 10% Owner | Buy(P) | 890K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2020-03-30 → 2026-07-31. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).